Key result
Highest hypertension treatment intensification linked to ~53% lower risk of incident ischemic stroke.
Why the study?
Does greater engagement in hypertension care reduce incident ischemic stroke in adults with hypertension?
Case-Control (n=40,428)
Does greater engagement in hypertension care reduce incident ischemic stroke in adults with hypertension?
Odds Ratio: 0.47 (95% CI 0.44–0.51)
Greater engagement in routine hypertension care, particularly through treatment intensification and frequent blood pressure monitoring, is associated with significantly lower odds of ischemic stroke.
May support hypertension care metrics for stroke prevention; leaves open causal confirmation in prospective trials.
BACKGROUND: Hypertension is the leading modifiable risk factor for ischemic stroke, yet the adequacy of preventative hypertension care in routine clinical practice remains suboptimal, potentially representing missed opportunities for stroke prevention. We evaluated the association between hypertension care delivery and incident ischemic stroke. METHODS: We conducted a retrospective, matched, nested case-control study among adults with hypertension using data from a large regional health system (2010-2024). Patients with a first-ever ischemic stroke were matched 1:2 to controls on age, sex, race and ethnicity, and calendar time. Three care metrics were assessed: (1) outpatient visits with blood pressure measurement per year; (2) number of antihypertensive medication ingredients; and (3) medication intensification score. Conditional logistic regression estimated adjusted odds ratios. RESULTS: The study included 13 476 cases and 26 952 matched controls. Cases had fewer blood pressure visits per year (median, 2.50 versus 3.01), similar number of medication ingredients (2.00 versus 2.00), and lower treatment intensification scores (-0.211 versus -0.125). Compared with ≤1 visit, >5 blood pressure visits per year was associated with lower stroke odds (adjusted odds ratio, 0.55 [95% CI, 0.51-0.59]). Use of 2 to 3 medication ingredients (versus 0) was also associated with reduced stroke odds (adjusted odds ratio, 0.80 [95% CI, 0.75-0.86]), whereas >3 ingredients was not. The highest quartile of treatment intensification showed the strongest association (adjusted odds ratio, 0.47 [95% CI, 0.44-0.51]). Findings were consistent across subgroup and sensitivity analyses. CONCLUSIONS: Greater engagement in hypertension care was associated with lower odds of ischemic stroke, suggesting that gaps in routine management may represent missed opportunities for prevention.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted a case-control in Hypertension (n=40,428). Hypertension care delivery (blood pressure visits, medication ingredients, treatment intensification) vs. Lower levels of hypertension care was evaluated on Incident ischemic stroke (OR 0.47, 95% CI 0.44-0.51). The highest quartile of hypertension treatment intensification was associated with lower odds of incident ischemic stroke (adjusted OR 0.47; 95% CI 0.44-0.51).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: